Utama › Poliradikuloneuropati Demielinasi Inflamatori Kronik › North Carolina
Kajian klinikal Poliradikuloneuropati Demielinasi Inflamatori Kronik di North Carolina
6 kajian untuk Poliradikuloneuropati Demielinasi Inflamatori Kronik sedang mencari peserta di lokasi di North Carolina.
Teks kajian rasmi (Bahasa Inggeris)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1635, Chapel Hill
- Site Number - 1610, Charlotte
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07032662Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- The Neurological Institute, PA, Charlotte
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05327114A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Raleigh Neurology Associates- Site Number : 8400043, Raleigh
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06290141Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
- PPD Virtual, Wilmington
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Apr 2026 · NCT07264426A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- University of North Carolina (UNC), Chapel Hill
- Duke University Hospital, Durham
- Raleigh Neurology Associates, Raleigh
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Jan 2026 · NCT06747351A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
- Wake Forest University - School of Medicine - Central, Winston-Salem
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Nov 2025 · NCT06538064Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.